FDA grants Mylan generic approval of Astra high blood pressure pill

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Mylan Pharmaceuticals has received approval from the FDA for its abbreviated new drug application for felodipine, the generic high blood pressure extended-release tablets USP, 2.5 mg, 5 mg and 10 mg.

Felodipine extended-release tablets USP are the generic version of AstraZeneca Pharmaceutical’s Plendil extended-release tablets, which had U.S. sales of approximately $251 million for the 12 months ending Dec. 31, 2007, according to IMS Health.

The Pittsburgh-based Mylan said it will start shipping felodipine immediately.